- Home
- CRMD vs DLY Comparison
CRMD vs DLY Comparison
Compare CRMD & DLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- DLY
- Stock Information
- Founded
- CRMD 2006
- DLY 2019
- Country
- CRMD United States
- DLY United States
- Employees
- CRMD N/A
- DLY N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- DLY Investment Managers
- Sector
- CRMD Health Care
- DLY Finance
- Exchange
- CRMD Nasdaq
- DLY Nasdaq
- Market Cap
- CRMD 849.8M
- DLY 703.9M
- IPO Year
- CRMD 2010
- DLY N/A
- Fundamental
- Price
- CRMD $13.18
- DLY $15.68
- Analyst Decision
- CRMD Strong Buy
- DLY
- Analyst Count
- CRMD 6
- DLY 0
- Target Price
- CRMD $15.00
- DLY N/A
- AVG Volume (30 Days)
- CRMD 1.7M
- DLY 215.9K
- Earning Date
- CRMD 05-06-2025
- DLY 01-01-0001
- Dividend Yield
- CRMD N/A
- DLY 8.93%
- EPS Growth
- CRMD N/A
- DLY N/A
- EPS
- CRMD 0.28
- DLY N/A
- Revenue
- CRMD $82,553,827.00
- DLY N/A
- Revenue This Year
- CRMD $238.38
- DLY N/A
- Revenue Next Year
- CRMD $53.52
- DLY N/A
- P/E Ratio
- CRMD $47.48
- DLY N/A
- Revenue Growth
- CRMD N/A
- DLY N/A
- 52 Week Low
- CRMD $3.61
- DLY $13.26
- 52 Week High
- CRMD $13.85
- DLY $15.95
- Technical
- Relative Strength Index (RSI)
- CRMD 69.49
- DLY 60.25
- Support Level
- CRMD $11.88
- DLY $15.65
- Resistance Level
- CRMD $12.90
- DLY $15.78
- Average True Range (ATR)
- CRMD 0.55
- DLY 0.14
- MACD
- CRMD -0.07
- DLY 0.02
- Stochastic Oscillator
- CRMD 90.00
- DLY 78.13
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest
DoubleLine Yield Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to seek a high level of total return, with an emphasis on current income. The company invests in debt securities and other income-producing investments of issuers anywhere in the world, including in emerging markets, and may invest in investments of any credit quality. Its investment portfolio comprises foreign corporate bonds, foreign government bonds, non-agency commercial mortgage-backed obligations, U.S. corporate bonds, collateralized loan obligations, and bank loans among other securities.